WHITE PAPERS
White papers to help you Control Medical Drug Spend.
DRUG ALERTS
Specialty Drug Pipeline Review to help you Control Medical Drug Spend.
LEARN MORE
See how we can solve your reimbursement and coding challenges.
WEBINARS
Webinars to help you Control Medical Drug Spend.
White Papers
Improving Claim Submission Accuracy Starts With Provider Engagement Through Greater Transparency: A Case Study on NDC Mandates
Optimization of Specialty Drug Cost Under the Medical Benefit Part 01
Optimization of Specialty Drug Cost Under the Medical Benefit Part 02
Insights into the U.S. Biosimilar Marketplace
Fraud, Waste, and Abuse Issues and Avoidance Specific to Medical Drug Claims
Medical Drug Claim Edits to Optimize Reimbursement
Addressing Drug Wastage: A $3 Billion Challenge
Webinars
Overpayments and Fee Schedule Development
VIEW NOW
Controlling Medical Drug Spend: Clinical Workflows for ICD-10, Min/Max, and Age/Gender Policies
VIEW NOW
Controlling Medical Drug Spend: Increased Frequency of Medical Claims Errors
VIEW NOW
Controlling Medical Drug Spend: Why RJ Health?
VIEW NOW
The Path to Pricing and Coding Updates: Reaching the Payer Stakeholders That Touch Claims
VIEW NOW
Quarterly Drug Coding, Reimbursement, and Pipeline Update Webinar – Q3 2019
VIEW NOW
Creating Pre-Payment Controls for Medically Covered Drug Costs through Automation
VIEW NOW
Introduction to Leveraging Data to Prevent and Recover Fraud, Waste and Abuse in Medical Drug Claims
VIEW NOW
The Path to Pricing and Coding Updates: Pricing Submissions and Compendia Update Challenges
VIEW NOW
Where is my NDC? – 17 Minute On-Demand Webinar
VIEW NOW
Addressing Escalating Medical Benefit Drug Pricing
VIEW NOW
Optimization of Specialty Drug Costs Under the Medical Benefit
VIEW NOW
The Path to Pricing and Coding Updates: The Path to Launch and Pricing Updates
VIEW NOW
Shedding Light on Medically Covered Specialty Drug Pricing Methods
VIEW NOW
Demystifying the HCPCS Creation Process and its Relationship with Drugs Coming to Market
VIEW NOW
Utilizing NDCs for Medical Benefit Drugs – A Payor’s Perspective
VIEW NOW
Pricing Medical Drug Claims – 18 Minute On-Demand Webinar
VIEW NOW
Vaccine Coding Challenges – 13 Minute On-Demand Webinar
VIEW NOW
Solving for Incorrectly Mapped NDC to HCPCS/CPT® Codes and Improperly Reported NDC Units
VIEW NOW
Precision Medicine for Health Plans
VIEW NOW
Specialty Drug Alerts
Our current collection of specialty drug pipeline reviews available to Drug Alerts subscribers includes:
Luspatercept (Reblozyl®)
Original FDA Approval: November 8, 2019
Last Updated: November 12, 2019
DOWNLOAD NOW
Eptinezumab
PDUFA: February 21, 2020
Last Updated: November 12, 2019
DOWNLOAD NOW
RVT-802
PDUFA: December 5, 2019
Last Updated: November 12, 2019
DOWNLOAD NOW
Diroximel Fumarate (VumerityTM)
Original FDA Approval: October 29, 2019
Last Updated: November 12, 2019
DOWNLOAD NOW
Brolucizumab
Original FDA Approval: October 7, 2019
Last Updated: October 7, 2019
DOWNLOAD NOW
Ravulizumab-cwvz (Ultomiris™)
Original FDA Approval: December 21, 2018 Last Updated: August 27, 2019
DOWNLOAD NOW
Teriparatide
Original FDA Approval: November 26, 2002
Last Updated: August 15, 2019
DOWNLOAD NOW
Riluzole
Original FDA Approval: December 21, 1995
Last Updated: July 20, 2019
DOWNLOAD NOW
Avatrombopag (Doptelet®)
Original FDA Approval: May 21, 2019
Last Updated: June 26, 2019
DOWNLOAD NOW
Tafamidis meglumine (Vyndaqel®)
Original FDA Approval: May 3, 2014
Last Updated: June 11, 2019
DOWNLOAD NOW
Ruxolitinib phosphate (Jakafi®)
Original FDA Approval: November 16, 2011
Last Updated: May 24, 2019
DOWNLOAD NOW
Ado-trastuzumab emtansine (Kadcyla®)
Original FDA Approval: February 22, 2013
Last Updated: May 9, 2019
DOWNLOAD NOW
Romosozumab-aqqg (Evenity™)
Original FDA Approval: April 9, 2019
Last Updated: April 9, 2019
DOWNLOAD NOW
Tipiracil hydrochloride + Trifluridine (Lonsurf®)
Original FDA Approval: September 22, 2015
Last Updated: February 28, 2019
DOWNLOAD NOW
Calaspoagase Pegol-mknl (Asparlas™)
Original FDA Approval: December 20, 2018
Last Updated: February 4, 2019
DOWNLOAD NOW
Cemiplimab-rwlc (Libtayo®)
Original FDA Approval: September 9, 2018
Last Updated: October 15, 2018
DOWNLOAD NOW
Patisiran (Onpattro™)
Original FDA Approval: August 10, 2018
Last Updated: August 13, 2018
DOWNLOAD NOW
Erenumab-aooe (Aimovig™)
Original FDA Approval: May 17, 2018
Last Updated: March 9, 2018
DOWNLOAD NOW
Sacituzumab Govitecan
Complete Response Letter: January 17, 2019
Last Updated: January 17, 2019
DOWNLOAD NOW
Ibalizumab-uiyk (Trogarzo™)
Original FDA Approval: March 6, 2018
Last updated: March 6, 2018
DOWNLOAD NOW
Nintedinab (Ofev®)
Original FDA Approval: October 15, 2019
Last Updated: October 21, 2019
DOWNLOAD NOW
Niraparib (Zejula®)
PDUFA: October 10, 2019
Last Updated: September 19, 2019
DOWNLOAD NOW
Upadacitinib
Original FDA Approval: August 16, 2019
Last Updated: August 19, 2019
DOWNLOAD NOW
Daratumumab (Darzalex®)
Original FDA Approval: November 16, 2015
Last Updated: August 12, 2019
DOWNLOAD NOW
OnabotulinumtoxinA (Botox®)
Original FDA Approval: April 12, 2002
Last Updated: August 2, 2019
DOWNLOAD NOW
Golodirsen
PDUFA: August 19, 2019
Last Updated: July 17, 2019
DOWNLOAD NOW
Celiprolol (Edsivo™)
Complete Reponse Letter: June 25, 2019
Last Updated: June 25, 2019
DOWNLOAD NOW
Galcanezumab-gnlm (Emgality®)
Original FDA Approval: September 27, 2018
Supplemental Approval: June 04, 2019
DOWNLOAD NOW
Onasemnogene abeparvovec-xioi (Zolgensma®)
Original FDA Approval: May 24, 2019
Last Updated: May 24, 2019
DOWNLOAD NOW
Risankizumab-rzaa (Skyrizi™)
Original FDA Approval: April 23, 2019
Last Updated: April 25, 2019
DOWNLOAD NOW
Siponimod (Mayzent®)
Original FDA Approval: March 26, 2019
Last Updated: March 26, 2019
DOWNLOAD NOW
Caplacizumab (Cablivi™)
Original FDA Approval: February 6, 2018
Last Updated: February 20, 2019
DOWNLOAD NOW
Venetoclax (Venclexta ®)
Original FDA Approval: April 11, 2016
Last Updated: January 17, 2019
DOWNLOAD NOW
Fremanezumab-vfrm (Ajovy™)
Original FDA Approval: September 14, 2018
Last Updated: September 24, 2018
DOWNLOAD NOW
Mogamulizumab-kpkc (Poteligeo ®)
Original FDA Approval: August 8, 2018
Last Updated: August 10, 2018
DOWNLOAD NOW
Tildrakizumab-asmn (Ilumya™)
Original FDA Approval: March 20, 2018
Last Updated: February 28, 2018
DOWNLOAD NOW
Brolucizumab-dbll (Beovu®)
Original FDA Approval: October 7, 2019
Last Updated: October 7, 2019
DOWNLOAD NOW